baclofen has been researched along with Cardiometabolic Syndrome in 1 studies
Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García, Mdel C | 1 |
| Godoy, YC | 1 |
| Celuch, SM | 1 |
1 other study available for baclofen and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Impaired hypotensive responses induced by intrathecally injected drugs in fructose-fed rats.
Topics: Animals; Arachidonic Acids; Baclofen; Blood Glucose; Blood Pressure; Calcitonin Gene-Related Peptide | 2013 |